Medtronic (NYSE:MDT) received CE Mark approval in Europe for its Affera Sphere-360 pulsed field ablation catheter for cardiac ablation procedures. The company has started pivotal U.S. clinical trials ...

Pulsed-field ablation, transcatheter heart valves, and IVL are among the top stories, as they drive growth among the largest ...

Jennifer Adamy, a 43-year-old cardiac nurse living in New Smyrna Beach, Florida, was very familiar with the signs of heart problems. So, when she started experiencing symptoms of irregular heart ...

Please provide your email address to receive an email when new articles are posted on . Insertable cardiac monitoring was estimated to be cost-effective for AF detection in the U.S. This finding was ...

Clinicians insert the Reveal LINQ Insertable Cardiac Monitor in the upper left side of a patient’s chest during a minimally invasive procedure. The implanted device allows clinicians to continuously ...

Medtronic (NYSE:MDT) received a CE mark for its Affera Sphere-360 pulsed field ablation catheter, opening access to European ...

The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...

After receiving the necessary regulatory approval, Medtronic is launching its latest product on the global market. The medical devices company announced on Wednesday that it has received clearance ...

SARASOTA, Fla.--(BUSINESS WIRE)-- PaceMate ®, a pioneer in cardiac data management and remote monitoring, announced today the acquisition of the Paceart Optima ™ system, an on-premises cardiac ...

Upgraded Medtronic to a ‘Buy’ rating with a fair value of $105 per share, driven by strong growth in Cardiac Ablation Solutions and TAVR markets. Medtronic reported 4.1% organic revenue growth and 6.2 ...